| Cannabidiol and tetrahydrocannabinol concentrations in commercially available CBD E-liquids in Switzerland KE Grafinger, S Krönert, A Broillet, W Weinmann Forensic science international 310, 110261, 2020 | 52 | 2020 |
| Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using … KE Grafinger, MM Vandeputte, A Cannaert, A Ametovski, E Sparkes, ... Drug testing and analysis 13 (7), 1412-1429, 2021 | 41 | 2021 |
| Clinical value of analytical testing in patients presenting with new psychoactive substances intoxication KE Grafinger, ME Liechti, E Liakoni British journal of clinical pharmacology 86 (3), 429-436, 2020 | 38 | 2020 |
| Study of the in vitro and in vivo metabolism of the tryptamine 5‐MeO‐MiPT using human liver microsomes and real case samples KE Grafinger, M Hädener, S König, W Weinmann Drug testing and analysis 10 (3), 562-574, 2018 | 33 | 2018 |
| Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using … E Pike, KE Grafinger, A Cannaert, A Ametovski, JL Luo, E Sparkes, ... Drug testing and analysis 13 (7), 1383-1401, 2021 | 28 | 2021 |
| Effects of Hypericum perforatum (St John's wort) on the pharmacokinetics and pharmacodynamics of rivaroxaban in humans I Scholz, E Liakoni, F Hammann, KE Grafinger, U Duthaler, M Nagler, ... British journal of clinical pharmacology 87 (3), 1466-1474, 2021 | 24 | 2021 |
| Structure–activity relationships of valine, tert-leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA … E Sparkes, EA Cairns, RC Kevin, F Lai, KE Grafinger, S Chen, ... RSC medicinal chemistry 13 (2), 156-174, 2022 | 22 | 2022 |
| New synthetic cannabinoids carrying a cyclobutyl methyl side chain: human phase I metabolism and data on human cannabinoid receptor 1 binding and activation of Cumyl‐CBMICA and … B Haschimi, KE Grafinger, B Pulver, E Psychou, S Halter, LM Huppertz, ... Drug testing and analysis 13 (8), 1499-1515, 2021 | 20 | 2021 |
| In vitro phase I metabolism of three phenethylamines 25D‐NBOMe, 25E‐NBOMe and 25N‐NBOMe using microsomal and microbial models KE Grafinger, K Stahl, A Wilke, S König, W Weinmann Drug testing and analysis 10 (10), 1607-1626, 2018 | 20 | 2018 |
| Scheduling of new psychoactive substance the Swiss way: a review and critical analysis KE Grafinger, W Bernhard, W Weinmann Science & Justice 59 (4), 459-466, 2019 | 19 | 2019 |
| Investigating the ability of the microbial model Cunninghamella elegans for the metabolism of synthetic tryptamines KE Grafinger, A Wilke, S König, W Weinmann Drug testing and analysis 11 (5), 721-729, 2019 | 18 | 2019 |
| Pharmacological and metabolic characterization of the novel synthetic opioid brorphine and its detection in routine casework KE Grafinger, M Wilde, L Otte, V Auwärter Forensic science international 327, 110989, 2021 | 15 | 2021 |
| NNL-3: a synthetic intermediate or a new class of hydroxybenzotriazole esters with cannabinoid receptor activity? A Ametovski, EA Cairns, KE Grafinger, A Cannaert, MH Deventer, S Chen, ... ACS Chemical Neuroscience 12 (21), 4020-4036, 2021 | 8 | 2021 |
| Study of the in vitro and in vivo metabolism of 4-HO-MET PS Bruni, KE Grafinger, S Nussbaumer, S König, S Schürch, ... Forensic science international 290, 103-110, 2018 | 7 | 2018 |
| Investigation of the μ‐and κ‐opioid receptor activation by eight new synthetic opioids using the [35S]‐GTPγS assay: U‐47700, isopropyl U‐47700, U‐49900, U‐47931E, N‐methyl U … L Otte, M Wilde, V Auwärter, KE Grafinger Drug Testing and Analysis 14 (7), 1187-1199, 2022 | 6 | 2022 |
| Determination of the Cross-Reactivity of the Biological Metabolite (–)-trans-Δ9-Tetrahydrocannabinol-Carboxylic Acid-Glucuronide (THC-COOH-Gluc) for … KE Grafinger, W Weinmann Journal of analytical toxicology 45 (3), 291-296, 2021 | 5 | 2021 |
| Cytotoxicity of the synthetic cannabinoids 5C-AKB48, 5F-MDMB-PINACA, ADB-CHMINACA, MDMB-CHMICA and NM-2201 in A549 and TR146 cell lines KE Grafinger, HK Mandhair, A Broillet, J Gertsch, W Weinmann Forensic Toxicology 37, 398-411, 2019 | 4 | 2019 |
| Analysing and quantifying chronic stress‐associated endogenous steroids in hair samples KE Grafinger, W Kassis, CA Favre, D Aksoy, S Gaugler Drug Testing and Analysis, 2024 | 2 | 2024 |
| Interpreting mono-and poly-SCRA intoxications from an activity-based point of view: JWH-018 equivalents in serum as a comparative measure LK Janssens, MJ Sommer, KE Grafinger, M Hermanns-Clausen, ... Archives of Toxicology, 1-14, 2024 | 1 | 2024 |
| Metabolite markers for three synthetic tryptamines N‐ethyl‐N‐propyltryptamine, 4‐hydroxy‐N‐ethyl‐N‐propyltryptamine, and 5‐methoxy‐N‐ethyl‐N‐propyltryptamine MSS Bergh, IL Bogen, KE Grafinger, MA Huestis, ÅML Øiestad Drug Testing and Analysis, 2024 | 1 | 2024 |
